| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/24/2008 | US20080095747 Promotion of Cell Migration and Axon Regeneration in the Cns |
| 04/24/2008 | US20080095736 Biocompatible polymers and hydrogels and methods of use |
| 04/24/2008 | US20080095712 Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in living organisms |
| 04/24/2008 | US20080095703 Method For Checking And Controlling The Mammalian Lactic Acid Fermentation Process / Aerobic Glucose Fermentation Metabolic Pathway In Mammalian Organism |
| 04/24/2008 | CA2665528A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/23/2008 | EP1914554A2 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914305A1 GSK3 polypeptides |
| 04/23/2008 | EP1914237A2 Phosphonate ester antiviral compounds |
| 04/23/2008 | EP1914233A1 Peripherally-selective inhibitors of dopamine-b-hydroxylase and method of their preparation |
| 04/23/2008 | EP1914232A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/23/2008 | EP1913945A2 Composition based on a thiazolidinedione and metformin and its use |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1372673B1 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1272516B1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 04/23/2008 | EP1251824B1 Use of a beverage composition comprising a polyphosphate for treating dental erosion |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1219612B1 2-imino-1,3-thiazine derivatives |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | CN101166742A Novel lactam compound |
| 04/23/2008 | CN101166732A Cyanopyridine derivative and use thereof as medicine |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164577A Heat-clearing fire-evil-dispelling and summer-passing summerheat-relieving summer-passing tea |
| 04/23/2008 | CN101164573A Traditional Chinese medicine for treating cold stagnation infantile hernia |
| 04/23/2008 | CN101164554A Application of valeriana jatamansi jones in preparing veterinary medicine for treating pica |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN101164535A Anti-heatstroke use of teprenone |
| 04/23/2008 | CN101164530A Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383132C Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100382797C Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361783 Agonists for human PPAR alpha isoform; exhibit lipid-lowering effect, inhibitory effect on the arteriosclerosis, antiobesity effect, blood glucose-lowering effect; 2-{[3-(N-{[4-(3,5-bistrifluoromethylphenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenyl]methyl}butyric acid |
| 04/22/2008 | US7361774 therapeutic agent or prophylactic agent for a disease requiring neuronal protection, suppression for nitrogen monoxide (NO) production, inhibition for aldose reductase or suppression for interleukin production, foodstuff or feed; 1-(5,6,7,8,8a,10a-hexahydro-1,7-dihydroxy-8,8,10a-trimethyl-9H-xanthen-4-yl |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361744 Oligosaccharide derivative |
| 04/22/2008 | US7361685 Compounds for use in the treatment of skin conditions |
| 04/22/2008 | US7361681 Method of treating amytrophic lateral sclerosis using melatonin |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361677 Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase |
| 04/22/2008 | US7361676 Solid preparation containing single crystal form |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361660 Chemical compounds |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361638 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
| 04/22/2008 | US7361459 Antiviral inhibition of capsid proteins |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/22/2008 | CA2321687C Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor |
| 04/22/2008 | CA2318349C Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/22/2008 | CA2299366C Use of xanthophylls for improvement of duration of muscle function or treatment of muscle disorders or diseases |
| 04/22/2008 | CA2297082C Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 04/22/2008 | CA2279963C Dinucleotides and their use |
| 04/22/2008 | CA2270777C Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 04/22/2008 | CA2239582C A new therapeutic use for glycine |
| 04/22/2008 | CA2225807C Use of lamellarin-class alkaloids in methods of treatment |
| 04/17/2008 | WO2008045528A2 Methods and compositions for the treatment of cancer |
| 04/17/2008 | WO2008045461A2 Transdermal diethylstilbestrol for treating prostate cancer |
| 04/17/2008 | WO2008044798A1 Agent for introducing protein into cell |
| 04/17/2008 | WO2008044777A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 04/17/2008 | WO2008044770A1 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044729A1 Carboxylic acid derivative |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044691A1 Antidepressant agent |
| 04/17/2008 | WO2008044688A1 Urea derivative |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound |
| 04/17/2008 | WO2008044337A1 γ-GLOBIN INDUCER |
| 04/17/2008 | WO2008044331A1 Solid preparation comprising ibuprofen and tranexamic acid |
| 04/17/2008 | WO2008044127A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 04/17/2008 | WO2008044054A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008016665A3 Imidazoacridine compounds for treating flt3 -mediated disorders |
| 04/17/2008 | US20080091263 Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts |
| 04/17/2008 | US20080091024 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090909 negative regulator of cell growth factor receptor; pelorol (benzo(a)fluorene) related compounds from marine sponge species; antiinflammatory, antitumor agent, immunostimulant; control gene expression, differentiation, metabolism, phospholipid signaling pathway, signal tansduction |
| 04/17/2008 | US20080090907 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine |
| 04/17/2008 | US20080090901 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-chagas chemoprophylactic and therapeutical activities |
| 04/17/2008 | US20080090881 Treatment of diabetes with thiazolidinedione and metformin |
| 04/17/2008 | US20080090867 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |